All Advances shall be disbursed from whichever office or other place [[Organization B:Organization]] may designate from time to time and, together with any and all other Obligations of [[Organization A:Organization]] to [[Organization B:Organization]] or Lenders, shall be charged to [[Organization A:Organization]]' Account on [[Organization B:Organization]]'s books. During the Term, [[Organization A:Organization]]
The agreement of Lenders to make any Advance requested to be made on any date (including the initial Advance), is subject to the satisfaction of the following conditions precedent as of the date such Advance is made:
If Buyer proposes a new blade model, Seller will notify Buyer of any new product specific tools and modifications to the Production Facility and/or the Storage Facility that will be required for the production of the new model. It will be the responsibility of Buyer to provide and deliver such product specific tools to Seller at Buyers sole cost. Seller will quote a price for such new blade model and establish an initial Bill of Materials and Baseline Price Schedule for such model. [......].
In the event that Buyer proposes a new blade model during the Term, the parties agree to the Minimum Volume Obligation under this Agreement shall remain the same and any remaining Minimum Volume Obligation for a Purchase Time Period shall be applied to the new model provided that no other model is being produced in which case the parties shall agree on the allocation between the models. Seller shall quote a price for such new blade model and establish an initial bill of material, and delivery schedule for such model based on a maximum of [ ] calculated using agreed on [ ]. The price quoted by Seller shall also include [ ] shall be documented in writing by Seller).
Test an additional in vivo model (e.g. )
Test an additional in vivo model (e.g. PC-3)
Suspensions of were tolerable, but not pharmacologically active in a rabbit hyperpermeability model.
Suspensions of a were tolerable and pharmacologically active in a pig uveitis model.
IFRS 9 replaces the ‘incurred loss model’ in IAS 39 with an ‘expected credit loss’ model. The measurement uses a dual measurement approach, under which the loss allowance is measured as either 12 month expected credit losses or lifetime expected credit losses. The standard also introduces new presentation and disclosure requirements.
Minimum Amount of Each Advance. Each Eurocurrency Advance shall be in the Dollar Amount of $5,000,000 or a higher integral multiple of 1,000,000 units of the applicable Agreed Currency. Each Floating Rate Advance (other than a Swingline Loan) shall be in the amount of $5,000,000 or a higher integral multiple of $1,000,000 and each Swingline Loan shall be in the amount of $500,000 or a higher integral multiple of $100,000; provided that any Floating Rate Advance of Revolving Loans may be in the amount of the unused Aggregate Revolving Commitment.
AllDrafts is a cloud-based editor designed specifically for contracts. With automatic formatting, a massive clause library, smart redaction, and insanely easy templates, it’s a welcome change from Word.
And AllDrafts generates clean Word and PDF files from any draft.